Kevin Albuquerque

Kevin Albuquerque, M.D., is a Professor and Chief of Gynecological Radiation Oncology Service at the University of Texas Southwestern Medical Center. He holds a medical degree from Bombay University, India, and completed residencies in surgical oncology and radiation oncology at institutions in India and the U.K. Dr. Albuquerque's career spans over two decades, including faculty roles at Loyola University Medical Center (2002–2012) and current leadership at UTSW.

His expertise lies in radiation oncology, particularly gynecological cancers, brachytherapy, and clinical trials. Key research focuses include optimizing adaptive radiotherapy, brachytherapy techniques, and investigating prognostic markers like MLH1 promoter hypermethylation in endometrial and cervical cancers. He has secured grants from Loyola Cancer Center and NIH, exploring breast brachytherapy, immune markers, and decision-making in breast cancer treatments.

Dr. Albuquerque’s work emphasizes translational research, quality-of-life outcomes, and clinical guidelines, such as the ASTRO guidelines for endometrial cancer. He actively collaborates on multi-institutional studies and contributes to innovation in AI-driven radiation therapy education and planning.